| Systems vaccinology of the BNT162b2 mRNA vaccine in humans PS Arunachalam, MKD Scott, T Hagan, C Li, Y Feng, F Wimmers, ... Nature 596 (7872), 410-416, 2021 | 467 | 2021 |
| Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination K Röltgen, SCA Nielsen, O Silva, SF Younes, M Zaslavsky, C Costales, ... Cell 185 (6), 1025-1040. e14, 2022 | 434 | 2022 |
| Proinflammatory IgG Fc structures in patients with severe COVID-19 S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... Nature immunology 22 (1), 67-73, 2021 | 299 | 2021 |
| Modeling human adaptive immune responses with tonsil organoids LE Wagar, A Salahudeen, CM Constantz, BS Wendel, MM Lyons, ... Nature medicine 27 (1), 125-135, 2021 | 230 | 2021 |
| Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection VVA Mallajosyula, M Citron, F Ferrara, X Lu, C Callahan, GJ Heidecker, ... Proceedings of the National Academy of Sciences 111 (25), E2514-E2523, 2014 | 216 | 2014 |
| KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 J Li, M Zaslavsky, Y Su, J Guo, MJ Sikora, V van Unen, A Christophersen, ... Science 376 (6590), eabi9591, 2022 | 210 | 2022 |
| Stalking influenza by vaccination with pre-fusion headless HA mini-stem SA Valkenburg, VVA Mallajosyula, OTW Li, AWH Chin, G Carnell, ... Scientific reports 6 (1), 22666, 2016 | 153 | 2016 |
| CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19 V Mallajosyula, C Ganjavi, S Chakraborty, AM McSween, ... Science immunology 6 (61), eabg5669, 2021 | 146 | 2021 |
| SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand? S Chakraborty, V Mallajosyula, CM Tato, GS Tan, TT Wang Advanced drug delivery reviews 172, 314-338, 2021 | 112 | 2021 |
| Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery SH Chiou, D Tseng, A Reuben, V Mallajosyula, IS Molina, S Conley, ... Immunity 54 (3), 586-602. e8, 2021 | 109 | 2021 |
| Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity S Chakraborty, JC Gonzalez, BL Sievers, V Mallajosyula, S Chakraborty, ... Science Translational Medicine 14 (635), eabm7853, 2022 | 108 | 2022 |
| Outflanking immunodominance to target subdominant broadly neutralizing epitopes D Angeletti, I Kosik, JJS Santos, WT Yewdell, CM Boudreau, ... Proceedings of the National Academy of Sciences 116 (27), 13474-13479, 2019 | 77 | 2019 |
| Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1* 15 alleles VE Saper, MJ Ombrello, AH Tremoulet, G Montero-Martin, S Prahalad, ... Annals of the rheumatic diseases 81 (3), 406-415, 2022 | 76 | 2022 |
| A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2 Q Yin, W Luo, V Mallajosyula, Y Bo, J Guo, J Xie, M Sun, R Verma, C Li, ... Nature Materials 22 (3), 380-390, 2023 | 67 | 2023 |
| Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection F Gao, V Mallajosyula, PS Arunachalam, K van der Ploeg, M Manohar, ... Immunity 56 (4), 864-878. e4, 2023 | 59* | 2023 |
| Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines TC Sutton, S Chakraborty, VVA Mallajosyula, EW Lamirande, K Ganti, ... NPJ vaccines 2 (1), 35, 2017 | 51 | 2017 |
| mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition K Röltgen, SCA Nielsen, PS Arunachalam, F Yang, RA Hoh, OF Wirz, ... MedRxiv, 2021 | 46 | 2021 |
| Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype VVA Mallajosyula, M Citron, F Ferrara, NJ Temperton, X Liang, JA Flynn, ... Frontiers in immunology 6, 329, 2015 | 44 | 2015 |
| Immunogen design for HIV-1 and influenza U Rathore, S Kesavardhana, VVA Mallajosyula, R Varadarajan Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1844 (11), 1891-1906, 2014 | 31 | 2014 |
| Symptomatic SARS-CoV-2 infections display specific IgG Fc structures S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... | 29 | 2020 |
